Published in Cancer Res on March 15, 1988
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med (2013) 1.21
Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9. Cell Mol Gastroenterol Hepatol (2016) 1.02
Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation. Proteomics (2012) 0.94
Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Am J Pathol (1990) 0.88
Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel) (2010) 0.86
CA 19-9 and pancreatic cancer. Clin Adv Hematol Oncol (2013) 0.86
Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br J Cancer (1989) 0.84
The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. J Gastric Cancer (2014) 0.83
Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins. J Proteome Res (2015) 0.82
Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A. Mol Cell Proteomics (2015) 0.79
The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities. Adv Cancer Res (2015) 0.79
Diagnostic utility of clinical and biochemical parameters in pancreatic head malignancy patients with normal carbohydrate antigen 19-9 levels. Afr Health Sci (2015) 0.78
Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther (2017) 0.75
Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol (1973) 3.45
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol (1997) 3.18
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet (2001) 3.01
IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther (2000) 2.59
Purification and properties of H+-translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem (1985) 2.54
AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology (1999) 2.34
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res (1987) 2.14
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res (1993) 2.08
Cardiac troponin I in calves with congenital heart disease. J Vet Intern Med (2012) 1.97
Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem Biophys Res Commun (2003) 1.93
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer (2008) 1.93
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res (1994) 1.90
Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. J Med Chem (1998) 1.88
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med (1981) 1.85
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res (1982) 1.75
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery (1989) 1.66
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med (1996) 1.56
Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene (2001) 1.49
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members. J Nucl Med (2001) 1.47
Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol (1982) 1.42
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Purification of human interleukin 1. J Supramol Struct (1980) 1.38
Human T cell antigen expression by primate T cells. Science (1982) 1.35
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer (2005) 1.34
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer (1981) 1.33
Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis (1993) 1.30
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res (1988) 1.22
Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A (2000) 1.19
Do shorter-acting neuromuscular blocking drugs or opioids associate with reduced intensive care unit or hospital lengths of stay after coronary artery bypass grafting? CABG Clinical Benchmarking Data Base Participants. Anesthesiology (1998) 1.17
Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin Pharmacol Ther (1991) 1.16
Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res (1985) 1.16
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology (2007) 1.16
CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther (2002) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg (1987) 1.13
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. Br J Cancer (2013) 1.12
Role of uppermost superficial surface layer of articular cartilage in the lubrication mechanism of joints. J Anat (2001) 1.12
Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein. Gastroenterology (1979) 1.12
Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg (1993) 1.11
Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst (1984) 1.11
A method for studying isolated resistance vessels from rabbit mesentery and brain and their responses to drugs. Circ Res (1967) 1.10
Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis (1995) 1.10
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Purification of yeast vacuolar membrane H+-ATPase and enzymological discrimination of three ATP-driven proton pumps in Saccharomyces cerevisiae. Methods Enzymol (1988) 1.08
Assessment of central, peripheral, and autonomic nervous system functions in lead workers: neuroelectrophysiological studies. Environ Res (1993) 1.07
Molecular cloning and sequence analysis of the human ribosomal protein S16. J Biol Chem (1991) 1.07
In vitro studies of the response of hamster lymphocytes to phytohemagglutinin and antigenic stimulation. J Immunol (1971) 1.06
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
Radiographic demonstration of common bile duct varices. Gastrointest Radiol (1982) 1.05
The study of normal and malignant cell antigens by mixed agglutination. Cancer Res (1968) 1.05
Histogenesis of exocrine pancreatic cancer in the hamster model. Environ Health Perspect (1984) 1.01
Effects of sodium pentobarbital anesthesia and neurotrophic factor on the maintenance of acetylcholinesterase and butyrylcholinesterase in the preganglionically denervated superior cervical ganglion of the cat. Proc Natl Acad Sci U S A (1983) 1.00
Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis (1989) 1.00
Transdifferentiation of human islet cells in a long-term culture. Pancreas (2001) 0.99
Immunotherapy in patients with melanoma. Ann Surg (1973) 0.98
Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease. Cancer Treat Rep (1982) 0.98
Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98
Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines. J Immunol (1978) 0.98
Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J Biol Chem (1987) 0.98
HL-A antigenic loss in malignant transformation. J Natl Cancer Inst (1971) 0.97
Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE). Contraception (2003) 0.97
Spontaneous remission of parathyroid adenoma followed with ultrasonographic examinations. J Clin Ultrasound (1994) 0.97
Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters. Am J Pathol (1991) 0.96
Enhancement of pancreatic carcinogenesis in hamsters fed a high-fat diet ad libitum and at a controlled calorie intake. Cancer Res (1989) 0.96
Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. J Clin Invest (1980) 0.95
Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer. J Histochem Cytochem (2001) 0.95
Co-expression of human cancer-associated epitopes on mucin molecules. Int J Cancer (1987) 0.95
Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn J Pharmacol (1995) 0.94
Enhancement of experimental pancreatic cancer in Syrian golden hamsters by dietary fat. J Natl Cancer Inst (1981) 0.94
Human tumor-specific cytotoxic T cell lines generated from tumor-draining lymph node infiltrate. Transplant Proc (1988) 0.94
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer (2013) 0.94
Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas (1989) 0.94
Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus (2011) 0.94
Maintenance of human islets in long-term culture. Differentiation (2000) 0.94
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Clin Cancer Res (2001) 0.94
Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver. J Clin Invest (1979) 0.93
Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Res (1992) 0.93
Neuroendocrine carcinoma in the nasal cavity of ten dogs. J Comp Pathol (2005) 0.93
Production of HL-A-specific antibodies in monkeys by immunization with soluble HL-A-antigens. Transplantation (1972) 0.93
Detection and partial characterization of human thymus-leukemia antigens. J Natl Cancer Inst (1980) 0.92
Pancreatic carcinogenicity of N-nitrosobis(2-oxopropyl)-amine in diabetic and non-diabetic Chinese hamsters. Cancer Lett (1987) 0.92
Selective induction of pancreatic ductular tumors by single doses of N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Cancer Lett (1978) 0.92
Characterization of high and low molecular weight lymphocyte-activating factor (interleukin I) from P388D and J774.1 mouse macrophage cell lines. J Reticuloendothel Soc (1980) 0.92
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Int J Cancer (1988) 0.92